Get the Stockscreener App
2.58
27.09%
0.55
Pre-market:
2.30
-0.28
-10.85%
Glucotrack Inc stock is traded at $2.58, with a volume of 51.26M.
It is up +27.09% in the last 24 hours and up +676.17% over the past month.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.
See More
Previous Close:
$2.03
Open:
$2.43
24h Volume:
51.26M
Relative Volume:
5.17
Market Cap:
$2.06M
Revenue:
-
Net Income/Loss:
$-16.89M
P/E Ratio:
-0.1235
EPS:
-20.8847
Net Cash Flow:
$-16.44M
1W Performance:
+8.40%
1M Performance:
+676.17%
6M Performance:
+141.12%
1Y Performance:
-55.44%
1-Day Range:
$2.38
$3.25
1-Week Range:
$1.9977
$3.25
52-Week Range:
$0.25
$9.086
Glucotrack Inc Stock (GCTK) Company Profile
Name
Glucotrack Inc
Sector
Industry
Phone
972 (8) 675-7878
Address
301 RT 17 NORTH, RUTHERFORD
Compare GCTK vs ISRG, BDX, RMD, ALC, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
2.58 | 2.06M | 0 | -16.89M | -16.44M | -20.88 |
ISRG
Intuitive Surgical Inc
|
399.52 | 141.14B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
179.23 | 48.82B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
221.89 | 32.01B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
64.56 | 31.21B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
34.66 | 30.41B | 29.14B | 1.07B | 1.05B | 1.1956 |
Glucotrack Inc Stock (GCTK) Latest News
Form 424B5 GlucoTrack Inc For: 24 September By Investing.com - Investing.com India
GlucoTrack Announces Debt-Reducing Public Equity Offering - TipRanks
Glucotrack Prices $3.1 Million Registered Direct Offering of Stock and Pre-Funded Warrants - TradingView
Emerging Growth DRK GLND APUS GCTK Stocks in the News - FinancialContent
What's Going On With GlucoTrack Shares On Thursday? - benzinga.com
Medical device developer Glucotrack Inc. announces pricing of $3M public offering - ROI-NJ
GlucoTrack Jumps as New Platform Commercialization News Appears to Outweigh Fresh Offering - Quiver Quantitative
GCTK Stock Slides As Lokahi Platform And LT-100 Gain Steam - StocksToTrade
GCTK Stock Draws Traders As Lokahi Strategy Takes Shape - timothysykes.com
Lokahi Therapeutics and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai-2 Platform Growth and Clinical Development Priorities - marketscreener.com
Glucotrack prices $3.1 million public offering at $2.04/share - Investing.com
Glucotrack, Inc. Announces Pricing of $3 Million Public Offering - businesswire.com
GCTK Stock Draws Traders As Lokahi Pipeline And Financing Advance - StocksToTrade
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
GCTK Stock Draws Traders As Lokahi Pivot Accelerates - StocksToTrade
GCTK Stock Draws Traders As Lokahi Platform And LT-100 Advance - timothysykes.com
Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving Premarket - Benzinga
Glucotrack Stock Is Trending: Here's Why GCTK Jumped Over 80% After Hours - Benzinga
Lōkahi Therapeutics™ Advances its Proprietary ai² PIPELINE (formerly ai² Futures Lab) Process from Internal Asset Engine to Revenue-Generating Platform - 01net
Trending Stocks Today | Glucotrack Shoots up 92.61% Post-Market - moomoo.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Form 8K GlucoTrack Inc For: 23 September - Investing.com India
Form 4 GlucoTrack Inc For: 23 September By Investing.com - Investing.com Canada
GlucoTrack and Lōkahi Outline Post-Merger Strategic Focus - TipRanks
Shelved drug trove powers Glucotrack (NASDAQ: GCTK) ai² search for new therapies - Stock Titan
Glucotrack issues strategic update: LT-100 clinical study targeted, ai² platform expands university network - TradingView
Lōkahi Therapeutics™ and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai² Platform Growth and Clinical Development Priorities - businesswire.com
GlucoTrack Director Resigns Amid Merger Conflict Concerns - The Globe and Mail
Form 8K GlucoTrack Inc For: 18 September By Investing.com - Investing.com Nigeria
Glucotrack director Paul V. Goode resigns citing potential conflict of interest - Investing.com
Board member quits Glucotrack (GCTK) over merger conflict - Stock Titan
Glucotrack, Inc. Announces Resignation of Paul V. Goode from the Board of Directors, Effective September 14, 2026 - marketscreener.com
Alabama students identified more than 45 potential treatments - Stock Titan
Glucotrack (NASDAQ: GCTK) registers shares equal to 5,442% of stock outstanding - Stock Titan
GlucoTrack director Paul V. Goode resigns citing potential conflict of interest - Bitget
Glucotrack shareholders approve stock issuance proposals and amend warrant terms By Investing.com - Investing.com South Africa
Form 8K GlucoTrack Inc For: 14 September By Investing.com - Investing.com Canada
Glucotrack shareholders approve stock issuance proposals and amend warrant terms - Investing.com
Form 8K GlucoTrack Inc For: 14 September - Investing.com India
Form 8K GlucoTrack Inc For: 11 September By Investing.com - Investing.com Australia
Why Is GlucoTrack (GCTK) in Focus? - kalkinemedia.com
GCTK Stock Is Soaring Today — What Is Fueling The Surge? - Stocktwits
Glucotrack Prices $11.5 Million Convertible Note Financing - minichart.com.sg
Glucotrack secures $11.5M in convertible note financing By Investing.com - Investing.com Australia
Form 8K GlucoTrack Inc For: 11 September - Investing.com India
Glucotrack Closes $11.6M Senior Secured Convertible Notes; Generates $4.5M Cash in Private Placement - TradingView
Glucotrack raises $12M in discounted convertible note deal - Dealroom
GCTK: Stockholders approved two major stock issuance proposals, both meeting NASDAQ compliance - TradingView
Glucotrack Secures $11.5 Million Convertible Debt Financing - citybiz
Glucotrack secures $11.5M in convertible note financing - Investing.com
Glucotrack Announces $11.5 Million Financing - Finviz
Glucotrack Inc Stock (GCTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.23%
3.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):